Posts Tagged 'hip implants'

Lawsuit filed against J&J over misleading claims

Consumer advocacy group Center for Science in the Public Interest has filed a federal lawsuit over artificial sweetener Splenda Essentials, claiming that Johnson & Johnson subsidiary McNeil Nutritionals is misleading consumers about the product’s supposed health benefits.

In a press release, CSPI says that Splenda Essentials’ marketing is designed to give the false impression that the sweetener confers health benefits, such as helping its users lose weight and avoid disease.

The lawsuit ...

continue reading...

Government launches more inquiries into J&J

Even as Johnson & Johnson is settling previous charges that may cost about $2.2 billion, the government is making new inquiries into allegations that the company used illegal tactics to promote and market its drugs, the Wall Street Journal reports.

According to the Wall Street Journal, the U.S. Justice Department sent J&J’s Janssen Pharmaceuticals unit a letter in April, requesting documents related to the marketing and promotion of the antibiotic Doribax.

In ...

continue reading...

Despite problems, Johnson & Johnson making money

The investment blog Seeking Alpha says Johnson & Johnson is doing quite well financially despite its recent problems – including high-profile and costly recalls of faulty medical devices.

The report notes that Warren Buffett’s Berkshire Hathaway Inc. dropped two-thirds of its holdings in the company, following a $1.1 billion fine from an Arkansas jury that ruled the firm misled doctors and patients about the risks of antipsychotic medication Risperdal.

Johnson & Johnson ...

continue reading...

J&J to pay $181 million in illegal marketing settlement

Johnson & Johnson will pay 36 states and the District of Columbia $181 million as a settlement for allegations that the company inappropriately marketed its antipsychotic drug Risperdal, the Philadelphia Inquirer reports.

Federal and state investigators have been examining the company’s Risperdal marketing practices for almost a decade, according to the Inquirer. The $181 million agreement is separate from a continuing federal investigation that could lead to criminal charges against Johnson ...

continue reading...

Troubled Johnson & Johnson issues another recall

A unit of Johnson & Johnson has issued a recall for certain lots of bone putty, which is used to stop bone bleeding by creating a physical barrier along the edges of bones damaged by trauma or cut during a surgical procedure.

Reuters reports that Synthes issued the recall on July 5, citing the potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during ...

continue reading...

Defibrillator concerns spotlight problems with medical devices

A cardiologist who conducted a study of St. Jude Medical defibrillator leads said surgeons should stop implanting them in patients until more research is done about safety concerns surrounding the devices.

The New York Times quotes Dr. Robert G. Hauser of Abbott Northwestern Hospital in Minneapolis as saying: “There is no need to use this lead until we have more confidence in its performance.”

The devices are wires that connect a patient’s ...

continue reading...
Page 19 of 34 «...101718192021...»